Munich - Delayed Quote EUR

Theriva Biologics Inc. R (SFY0.MU)

Compare
1.3600 0.0000 (0.00%)
As of October 31 at 9:19 AM GMT+1. Market Open.
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
20,246.0000
21,431.0000
21,581.0000
14,274.0000
10,160.0000
Operating Income
-20,246.0000
-21,431.0000
-21,581.0000
-14,274.0000
-10,160.0000
Net Non Operating Interest Income Expense
1,096.0000
1,439.0000
512.0000
6.0000
44.0000
Other Income Expense
-4,068.0000
3.0000
-41.0000
--
--
Pretax Income
-23,218.0000
-19,989.0000
-21,110.0000
-14,268.0000
-10,116.0000
Tax Provision
-951.0000
-1,640.0000
-1,425.0000
--
--
Net Income Common Stockholders
-22,267.0000
-18,349.0000
-20,025.0000
-23,189.0000
-12,557.0000
Diluted NI Available to Com Stockholders
-22,267.0000
-18,349.0000
-20,025.0000
-23,189.0000
-12,557.0000
Basic EPS
-1.25
-1.14
-1.31
-1.90
-6.60
Diluted EPS
-1.25
-1.14
-1.31
-1.90
-6.60
Basic Average Shares
17,669.7500
16,107.0140
15,327.3280
12,187.5040
1,901.1360
Diluted Average Shares
17,669.7500
16,107.0140
15,327.3280
12,187.5040
1,901.1360
Total Operating Income as Reported
-24,314.0000
-21,431.0000
-21,581.0000
-14,274.0000
-10,160.0000
Total Expenses
20,246.0000
21,431.0000
21,581.0000
14,274.0000
10,160.0000
Net Income from Continuing & Discontinued Operation
-22,267.0000
-18,349.0000
-19,685.0000
-14,267.0000
-10,043.0000
Normalized Income
-18,365.6237
-18,351.7540
-19,646.7675
-14,267.0000
-10,043.0000
Interest Income
1,096.0000
1,439.0000
512.0000
6.0000
44.0000
Net Interest Income
1,096.0000
1,439.0000
512.0000
6.0000
44.0000
EBIT
-20,246.0000
-21,431.0000
-21,581.0000
-14,274.0000
-10,160.0000
EBITDA
-20,098.0000
-21,296.0000
-21,496.0000
-14,187.0000
-9,959.0000
Reconciled Depreciation
148.0000
135.0000
85.0000
87.0000
201.0000
Net Income from Continuing Operation Net Minority Interest
-22,267.0000
-18,349.0000
-19,685.0000
-14,267.0000
-10,043.0000
Total Unusual Items Excluding Goodwill
-4,068.0000
3.0000
-41.0000
--
--
Total Unusual Items
-4,068.0000
3.0000
-41.0000
--
--
Normalized EBITDA
-16,030.0000
-21,299.0000
-21,455.0000
-14,187.0000
-9,959.0000
Tax Rate for Calcs
0.0000
0.0001
0.0001
--
--
Tax Effect of Unusual Items
-166.6237
0.2460
-2.7675
--
--
12/31/2020 - 1/12/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers